GXO Logistics (GXO) continued its expansion in healthcare logistics with the announcement of its appointment by NHS England as the managed service provider for the continued provision of Fecal Immunochemical Test home testing for eligible participants in the bowel cancer screening program across England. As part of the agreement, GXO will manage the supply and distribution of FIT kits working with partners, MAST and RDi.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GXO:
- GXO Logistics and Hasbro open U.S. distribution center
- GXO Logistics deploys first autonomous industrial truck in France
- Amentum, GXO Logistics and Accenture form Torus Defense Supply Chain
- GXO Logistics Appoints New Chief Financial Officer Suchinski
- GXO Logistics appoints Suchinski as Chief Financial Officer